Queenan's management of high-risk pregnancy : an evidence-based approach / edited by Charles J. Lockwood, Catherine Y. Spong
"In this new edition we have focused on including topics most critical to providing good care, each written by outstanding authorities on the subject to ensure they are focused, timely, and authoritative. This dynamic process requires adding new chapters as the evidence dictates and eliminating others so that the reader is presented with the most clinically useful contemporary information. We are delighted to ensure John T. Queenan's legacy continues in this latest edition, as we are committed to his vision and inspiration to have clear, concise protocols that ensure that busy practitioners have needed information at their fingertips. The seventh edition comes at a time when health care has experienced a pandemic, virtual visits and encounters are increasingly common, and health care settings continue to rapidly evolve. We continue to emphasize evidence-based information and clinical practicality and included chapters addressing timely topics such as infectious diseases in pregnancy, vaping, operative vaginal delivery, postpartum hemorrhage, and pregnancies in women with disabilities. To ensure applicability for health professionals in developing countries we have protocols on maternal anemia, malaria, and HIV infection"--.
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
Hoboken, NJ: Wiley-Blackwell ; 2024 |
| Ausgabe: |
Seventh edition |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Abweichender Titel: Management of high-risk pregnancy |
|---|
| Beteiligte Personen: |
Spong, Catherine Y. [HerausgeberIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Nlm: |
WQ 240 |
|---|---|
| Themen: |
Evidence-Based Medicine |
| Anmerkungen: |
Includes bibliographical references and index |
|---|
| Umfang: |
1 Online-Ressource |
|---|
| doi: |
10.1002/9781119636540 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1881315940 |
|---|
| LEADER | 01000nam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1881315940 | ||
| 003 | DE-627 | ||
| 005 | 20240221093846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240221s2024 xxu|||||o 00| ||eng c | ||
| 020 | |a 1119636531 |9 1-119-63653-1 | ||
| 020 | |a 111963654X |c electronic bk. |9 1-119-63654-X | ||
| 020 | |a 9781119636533 |9 978-1-119-63653-3 | ||
| 020 | |a 9781119636540 |c electronic bk. |9 978-1-119-63654-0 | ||
| 020 | |z 1119636493 | ||
| 020 | |z 9781119636496 | ||
| 024 | 7 | |a 10.1002/9781119636540 |2 doi | |
| 035 | |a (DE-627)1881315940 | ||
| 035 | |a (DE-599)KEP100813976 | ||
| 035 | |a (OCoLC)1422796011 | ||
| 035 | |a (WILEY)9781119636540 | ||
| 035 | |a (EBP)100813976 | ||
| 040 | |a DE-627 |b eng |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a RG571 | |
| 060 | 0 | |a WQ 240 | |
| 082 | 0 | |a 618.3 |2 22 | |
| 245 | 1 | 0 | |a Queenan's management of high-risk pregnancy |b an evidence-based approach |c edited by Charles J. Lockwood, Catherine Y. Spong |
| 246 | 1 | |i Abweichender Titel |a Management of high-risk pregnancy | |
| 250 | |a Seventh edition | ||
| 264 | 1 | |a Hoboken, NJ |b Wiley-Blackwell |c 2024 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 505 | 8 | 0 | |a Antiphospholipid antibody syndrome -- Management considerations in patients with inherited or acquired thrombophilia -- Inherited thrombophilia -- Antiphospholipid antibody syndrome -- Summary -- References -- Chapter 15 Thromboembolic Disorders -- Physiology of hemostasis -- Platelet plug formation -- The coagulation cascade -- Endogenous anticoagulants -- Pathophysiology of and risk factors for thrombosis in pregnancy -- Diagnosis of venous thromboembolism -- Deep venous thrombosis -- Pulmonary embolus -- Conclusion -- References -- Chapter 16 Cardiac Disease in Pregnancy -- Risk assessment and risk-appropriate care -- Antenatal care and optimization -- First trimester -- Second trimester -- Third trimester -- Multidisciplinary delivery planning -- Mode of delivery -- Analgesia and anesthesia -- Monitoring and emergency preparedness -- Postpartum and interconception care -- Conclusion -- References -- Chapter 17 Renal Disease -- Physiological changes in renal function during pregnancy -- Anatomic changes in the urinary tract during pregnancy -- Renal disease in pregnancy -- Proteinuria -- Chronic kidney disease -- Mild renal insufficiency -- Moderate and severe renal insufficiency -- Hypertensive disorders with renal insufficiency -- Renal dialysis -- Renal transplantation -- Management of pregnancies complicated by renal disease -- Conclusion -- References -- Chapter 18 Pregnancy in Transplant Patients -- Prepregnancy assessment and counseling -- Antepartum care -- Review of common agents for maintenance immunosuppression -- Kidney transplant -- Other organ transplant patients -- Kidney-pancreas -- Liver -- Heart -- Lung -- Other transplant groups -- Uterus -- Intrapartum management -- Obstetric emergencies -- The baby -- References -- Chapter 19 Gestational Diabetes Mellitus -- Risk factors for gestational diabetes. |
| 505 | 8 | 0 | |a Chapter 10 Interpreting Intrapartum Fetal Heart Tracings -- Components of EFM documentation -- Baseline FHR -- Baseline FHR variability -- Accelerations -- Decelerations -- Uterine contractions -- Changes and trends in FHR over time -- Interpretation of EFM -- Category I -- Category III -- Category II -- Management of FHR abnormalities in labor -- Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) -- Tachysystole with fetal heart rate changes -- Maternal hypotension -- Maternal repositioning -- Intravenous fluid bolus -- Maternal hyperoxygenation -- Amnioinfusion -- Fetal stimulation -- Future directions -- References -- Part 4 Maternal Disease -- Chapter 11 Sickle Cell Anemia -- Hemoglobin SCD -- Hemoglobin S/-thalassemia disease -- Management during pregnancy -- Acute pain -- Chronic pain -- Prophylactic red blood cell transfusions -- Other treatments -- Fetal assessment -- Labor and delivery -- Genetic evaluation -- CASE PRESENTATION -- References -- Chapter 12 Anemia -- Consequences -- Causes of anemia in pregnancy -- Diagnostic workup and treatment -- Macrocytic anemia -- Normocytic anemia -- Microcytic anemia -- Iron supplementation in pregnancy -- Treatment of iron deficiency anemia -- References -- Chapter 13 Thrombocytopenia -- Maternal thrombocytopenia -- Gestational thrombocytopenia -- Autoimmune thrombocytopenia -- HELLP -- Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome -- Other causes -- Fetal thrombocytopenia -- Autoimmune thrombocytopenia -- Alloimmune thrombocytopenia -- References -- Chapter 14 Inherited and Acquired Thrombophilias -- Overview of hemostasis changes during pregnancy -- Inherited thrombophilias -- Factor V Leiden -- Prothrombin gene mutation (G2021A) -- Protein C deficiency -- Protein S deficiency -- Antithrombin deficiency -- Acquired thrombophilia. |
| 505 | 8 | 0 | |a Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Acknowledgments -- Part 1 Factors of High-Risk Pregnancy -- Chapter 1 Overview of High-Risk Pregnancy -- Chapter 2 Nutrition in Pregnancy -- Fetal growth -- Body mass index, weight gain, and adverse pregnancy outcomes -- Obesity -- Nutrition assessment and counseling -- Food security -- Energy intake during pregnancy -- Healthy dietary pattern in pregnancy -- Multivitamins -- Micronutrients in pregnancy -- Iron -- Folate/folic acid -- Calcium -- Vitamin D -- Iodine -- Vitamin toxicity -- Caffeine consumption in pregnancy -- Seafood consumption in pregnancy -- Multifetal pregnancy -- Nutrition during lactation -- Conclusion -- References -- Chapter 3 Alcohol and Substance Use Disorder -- Introduction -- Screening and testing for substance use disorder -- Alcohol -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Opioids -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Intrapartum and postpartum care -- Cannabis -- Stimulants -- Vaping (E-cigarettes) -- Benzodiazepines -- References -- Chapter 4 Environmental Agents and Reproductive Risk -- Background incidence of adverse outcome -- Biologic evidence of toxicity -- General principles -- Specific agents -- Lead -- Mercury -- Pesticides and herbicides -- Polychlorinated biphenyls -- Polybrominated diphenyl ethers -- Organic solvents -- Perfluorochemicals -- Video display terminals -- Bisphenol A -- Phthalates -- Air pollutants -- References -- Part 2 Genetics -- Chapter 5 Genetic Screening for Mendelian Disorders -- Family history -- Mendelian inheritance -- Carrier screening -- Carrier screening guidelines -- Hemoglobinopathies -- Cystic fibrosis -- Spinal muscular atrophy -- Fragile X syndrome -- Jewish genetic diseases -- Prenatal diagnosis -- Newborn screening. |
| 505 | 8 | 0 | |a Therapeutic modalities in gestational diabetes -- Antenatal testing -- Delivery: when and how to deliver -- Postpartum considerations -- References -- Chapter 20 Diabetes Mellitus -- Initial evaluation -- Regulating maternal glycemia -- Management during pregnancy -- Management of insulin during labor -- References -- Chapter 21 Thyroid Disorders -- Diagnosis -- Additional studies -- Hypothyroidism -- Implications for pregnancy -- Treatment -- Hyperthyroidism -- Implications for pregnancy -- Management -- Thyroid storm management [3,4,10] -- References -- Chapter 22 Asthma -- Definition of asthma -- Effect of pregnancy on the course of asthma -- Clinical observations -- Mechanisms -- Effect of asthma on pregnancy -- Clinical observations -- Mechanisms -- Diagnosis of asthma during pregnancy -- Management -- Assessment and monitoring -- Control of factors contributing to severity -- Patient education -- Pharmacologic therapy -- Chronic asthma -- Acute asthma -- Management during labor and delivery -- Conclusion -- References -- Chapter 23 Epilepsy -- Contraception -- Fertility -- Preconception counseling -- Folic acid -- Seizures during pregnancy -- ASM risks: Structural and neurodevelopmental teratogenicity -- Management during pregnancy -- Prenatal screening -- ASM levels -- Peripartum care -- Labor and delivery -- Maternal outcomes -- Postpartum care -- ASM management and seizure risk -- Breastfeeding -- Postpartum depression -- Summary -- References -- Chapter 24 Chronic Hypertension -- Definition -- Diagnosis -- Preconceptional counseling -- Morbidity and mortality -- Diagnosis and evaluation in pregnancy -- Treatment during pregnancy -- Antepartum fetal assessment -- Delivery -- Postpartum care -- References -- Chapter 25 Systemic Lupus Erythematosus -- Epidemiology -- Etiology -- Pathogenesis -- Differential diagnosis -- Morbidity. |
| 520 | |a "In this new edition we have focused on including topics most critical to providing good care, each written by outstanding authorities on the subject to ensure they are focused, timely, and authoritative. This dynamic process requires adding new chapters as the evidence dictates and eliminating others so that the reader is presented with the most clinically useful contemporary information. We are delighted to ensure John T. Queenan's legacy continues in this latest edition, as we are committed to his vision and inspiration to have clear, concise protocols that ensure that busy practitioners have needed information at their fingertips. The seventh edition comes at a time when health care has experienced a pandemic, virtual visits and encounters are increasingly common, and health care settings continue to rapidly evolve. We continue to emphasize evidence-based information and clinical practicality and included chapters addressing timely topics such as infectious diseases in pregnancy, vaping, operative vaginal delivery, postpartum hemorrhage, and pregnancies in women with disabilities. To ensure applicability for health professionals in developing countries we have protocols on maternal anemia, malaria, and HIV infection"-- | ||
| 650 | 0 | |a Evidence-based medicine | |
| 650 | 0 | |a Pregnancy |x Complications | |
| 650 | 2 | |a Evidence-Based Medicine |x methods | |
| 650 | 2 | |a Pregnancy Complications | |
| 650 | 2 | |a Pregnancy, High-Risk | |
| 650 | 4 | |a Grossesse - Complications | |
| 650 | 4 | |a Grossesse à risques élevés | |
| 650 | 4 | |a Médecine factuelle | |
| 700 | 1 | |a Spong, Catherine Y. |e herausgeberin |4 edt | |
| 700 | 1 | |a Lockwood, Charles J. |e herausgeberin |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Queenan's management of high-risk pregnancy |b Seventh edition |d Hoboken, NJ : Wiley-Blackwell, 2024 |z 9781119636496 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/9781119636540 |m X:WILEY |x Verlag |z lizenzpflichtig |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781119636540 |m X:WILEY |x Verlag |z lizenzpflichtig |
| 912 | |a ZDB-35-UBC | ||
| 912 | |a ZDB-35-WIC | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a ISIL_DE-28 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a ISIL_DE-715 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a ISIL_DE-21 | ||
| 912 | |a GBV_ILN_2020 | ||
| 912 | |a ISIL_DE-Ch1 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a ISIL_DE-944 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 618.3 | ||
| 980 | |2 62 |1 01 |x 0028 |b 4494165646 |h OLR-Wiley-EBS |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |k Temporär im Bestand der UB Rostock |y z |z 29-02-24 | ||
| 980 | |2 120 |1 01 |x 0715 |b 4500370617 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 15-03-24 | ||
| 980 | |2 2001 |1 01 |x DE-21 |b 4489187955 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 21-02-24 | ||
| 980 | |2 2020 |1 01 |x DE-Ch1 |b 4505261786 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Campuslizenz |y l01 |z 28-03-24 | ||
| 980 | |2 2111 |1 01 |x DE-944 |b 4489187971 |c 00 |f --%%-- |d eBook Wiley |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 21-02-24 | ||
| 981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1002/9781119636540 | ||
| 981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016397245903501 | ||
| 981 | |2 2001 |1 01 |x DE-21 |r https://doi.org/10.1002/9781119636540 | ||
| 981 | |2 2020 |1 01 |x DE-Ch1 |r https://doi.org/10.1002/9781119636540 | ||
| 981 | |2 2111 |1 01 |x DE-944 |r https://doi.org/10.1002/9781119636540 | ||
| 982 | |2 2001 |1 01 |x DE-21 |8 00 |s s |a eBook-Wiley-UBCM-eBook-Collection-2018 | ||
| 983 | |2 2111 |1 01 |x DE-944 |8 00 |0 (DE-627)1353370437 |a e-Book | ||
| 995 | |2 62 |1 01 |x 0028 |a OLR-Wiley-EBS | ||
| 995 | |2 120 |1 01 |x 0715 |a alma | ||